Dr. Manoj Mittal, MD

Dr. Mittal practices at Sutter Medical Center, Sacramento in Sacramento, California, part of Sutter Health.

Dr. Mittal's NPI, 1528220720, was assigned on June 28, 2008. Dr. Mittal graduated from Delhi University College of Medical Sciences in 2005. Dr. Mittal holds California license A146354.

Dr. Mittal's primary practice is Sutter Medical Center, Sacramento, at 2825 Capitol Avenue, Sacramento, CA 95816 in Sacramento County. The practice phone is (916) 454-2222.

Dr. Mittal's primary practice is Sutter Medical Center, Sacramento in Sacramento, California, part of Sutter Health. Dr. Mittal is also affiliated with Sutter Roseville Medical Center. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Mittal to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mittal practices, 8 sites in all. Vendor and product names are available with a free account.

Neurocritical care is Dr. Mittal's primary specialty in the NPI Registry, under taxonomy code 2084A2900X. Dr. Mittal is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Mittal's licenses on file in 5 states: California, Oregon, Kansas, New York and Minnesota.

Dmand AI lists cerebrovascular disease and epilepsy among the conditions Dr. Mittal treats.

CMS data shows 541 Medicare services from Dr. Mittal across 4 procedure codes in 2024, for 280 Medicare patients. Medicare paid $80,106 for them.

CMS counts 280 Medicare patients who saw Dr. Mittal in 2024. The largest group is 75 to 84, with 109 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mittal's median patient age at 54, with 62% women.

In 2020, Dr. Mittal wrote 64 Medicare Part D claims. They cover 4 drugs, with $2,092 in total drug cost. In 2019, CMS named 47 claims across 3 drugs.

Dr. Mittal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mittal as offering telehealth.

Dmand AI links 24 papers to Dr. Mittal, published from 2012 to 2022. 2012 was the busiest year, with 2. The most frequent topics are Brain Ischemia, Stroke and Tomography, X-Ray Computed. Dr. Mittal has published most often in J Stroke Cerebrovasc Dis. Dr. Mittal's most frequent co-authors are Manoj K. Mittal, MD, Michael George Abraham, MD and Lalit Bajaj, MD.

Dmand AI links Dr. Mittal to 8 clinical trials, 6 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Cerebral Hemorrhage, Ischemic Stroke and Intracranial Hemorrhages. Johns Hopkins University sponsors the most, 2.

CMS Open Payments shows 27 general payments to Dr. Mittal from 13 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $211.

Dmand AI lists 2 awards for Dr. Mittal, most recently Resident research award in 2011.

Dr. Mittal graduated from Delhi University College of Medical Sciences in 2005. Dr. Mittal is a member of AAN and Neurocritical Care.

Dr. Mittal is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.